St. Petersburg State Pavlov Medical University
Clinical trials sponsored by St. Petersburg State Pavlov Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug cocktail aims to tame deadly transplant side effect Results expected Dec 2026 (estimated)
- Which airway method causes least coughing during sinus surgery? new study aims to find out Results expected Jan 2027 (estimated)
-
New hope for hodgkin lymphoma: maintenance drug after transplant
Disease control Recruiting nowThis study tests whether a drug called a PD-1 inhibitor can help keep Hodgkin lymphoma from coming back after a stem cell transplant. It is for people whose lymphoma returned or did not respond to earlier treatments. About 83 adults will receive the drug as maintenance therapy an…
Phase 2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Immunotherapy combo shows promise in hodgkin lymphoma trial
Disease control Recruiting nowThis study compares two first-line treatments for advanced Hodgkin lymphoma. One group gets a new combination of the immunotherapy drug nivolumab plus chemotherapy (AVD), while the other group receives standard chemotherapy (BEACOPP-like). The goal is to see which approach is saf…
Phase 2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug cocktail aims to tame deadly transplant side effect
Disease control Recruiting nowThis phase 2 trial tests whether adding two drugs, ruxolitinib and abatacept, to standard transplant care can prevent graft-versus-host disease (GVHD) in 60 patients with high-risk myeloid cancers like AML and MDS. Participants receive a stem cell transplant from a partially matc…
Phase 2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC